Patient Guide: REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07160231
Status: 🟢 Enrolling Now
Condition: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondyloarthritis (AxSpA)
Phase: PHASE4

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • Nijmegen, Gelderland
  • • Maastricht, Limburg
  • • Tilburg, North Brabant
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases - Join Clinical Trial NCTNCT07160231

How to Join This Clinical Trial - NCTNCT07160231

Learn how to participate in this PHASE4 trial studying an investigational therapy for Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondyloarthritis (AxSpA). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondyloarthritis (AxSpA). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondyloarthritis (AxSpA)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07160231 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

Nijmegen, Gelderland 6574 NA - Netherlands

Status: RECRUITING

Clinical Research Site

Maastricht, Limburg 6229 HX - Netherlands

Status: NOT_YET_RECRUITING

Clinical Research Site

Tilburg, North Brabant 5022 GC - Netherlands

Status: NOT_YET_RECRUITING

Clinical Research Site

Enschede, Overijssel 7512 KZ - Netherlands

Status: NOT_YET_RECRUITING

Clinical Research Site

Zwolle, Overijssel 8025 AB - Netherlands

Status: NOT_YET_RECRUITING

Clinical Research Site

Rotterdam, South Holland 3015 GD - Netherlands

Status: NOT_YET_RECRUITING

Clinical Research Site

Rotterdam, South Holland 3079 DZ - Netherlands

Status: NOT_YET_RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondyloarthritis (AxSpA):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships